What is IDLife?
IDLife operates at the intersection of personalized nutrition and direct-to-consumer commerce, offering a comprehensive suite of health-focused solutions. The company distinguishes itself through a data-driven approach to wellness, utilizing specialized assessments to tailor nutritional programs for individual users. Its product portfolio, which includes BioAge for cellular energy and NAD+ support, alongside structured programs like IDNutrition and Lean30, addresses the growing consumer demand for metabolic optimization and cellular resilience. By integrating a community-based business model, IDLife empowers independent associates to distribute its health products, effectively bridging the gap between professional-grade supplementation and accessible daily wellness habits.
How much funding has IDLife raised?
IDLife has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in IDLife
PPP
Public-Private Partnership
What's next for IDLife?
Looking ahead, the recent capital allocation is expected to catalyze IDLife's expansion into new demographic segments and geographic markets. The firm is likely to prioritize the enhancement of its digital assessment platforms, ensuring that its personalized nutrition algorithms remain at the forefront of the industry. Furthermore, the strategic deployment of these funds will likely focus on strengthening supply chain resilience and expanding the reach of its direct-to-consumer network. As the company transitions through this late-stage growth phase, the focus will remain on scaling its infrastructure to support a larger user base while maintaining the efficacy and quality of its nutritional offerings. This strategic pivot underscores a broader commitment to long-term market leadership in the wellness technology space.
See full IDLife company page
